Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imunon, Inc. - Common Stock (NQ: IMNN )

0.9799 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Imunon, Inc. - Common Stock

< Previous 1 2 Next >
IMNN Stock Earnings: Imunon Beats EPS for Q2 2024
IMNN stock results show that Imunon beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Peering Into Imunon's Recent Short Interest
Via Benzinga
Why Imunon (IMNN) Stock Is Down 60% Today
Imunon shares are trading lower by 61% during Wednesday's session. The company announced a $10 million registered direct offering. 
Via Benzinga
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
Via Benzinga
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Down 1%; JetBlue Airways Shares Spike Higher
Via Benzinga
IMNN Stock Earnings: Imunon Beats EPS for Q1 2024
IMNN stock results show that Imunon beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
IMNN Stock Earnings: Imunon Beats EPS for Q4 2023
IMNN stock results show that Imunon beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Preview: Imunon's Earnings
Via Benzinga
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nano-Cap IMUNON's Lead Candidate Shows Overall Survival Of Around 11 Months In Untreated Ovarian Cancer Patients
IMUNON shares surge on Tuesday with 105.5 million volume following positive Phase 2 OVATION 2 Study results for IMNN-001 in advanced ovarian cancer, showcasing significant improvements in survival... 
Via Benzinga
Imunon: Q3 Earnings Insights
Via Benzinga
Imunon's Earnings Outlook
Via Benzinga
Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results
Via Benzinga
Exposures Fossil Fuels
Dow Jumps 200 Points; Pfizer Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Imunon (IMNN) Stock Up 259% Today?
Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial. 
Via InvestorPlace
Why Is QXO (QXO) Stock Down 80% Today?
QXO stock is falling hard on Tuesday after the business application and technology company announced a private placement for its shares. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning! 
Via InvestorPlace
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Imunon Highlights Early Data From Lead Program In Ovarian Cancer
Imunon Inc (NASDAQ: IMNN) announces interim progression-free survival (PFS) and overall survival (OS) data with IMNN-001 in its Phase 1/2 OVATION 2 Study of intraperitoneal IMNN-001 in combination with... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.